HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritis.

HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritis.

<h4>Objective</h4>To provide a table indicating the risk for developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritis (RA) according to one's HLA-DRB1 genotype.<h4>Methods</h4>We HLA-DRB1 genotyped 857 patients with ACPA positive RA and 2178 co...

Full description

Bibliographic Details
Main Authors:	Nathalie Balandraud, Christophe Picard, Denis Reviron, Cyril Landais, Eric Toussirot, Nathalie Lambert, Emmanuel Telle, Caroline Charpin, Daniel Wendling, Etienne Pardoux, Isabelle Auger, Jean Roudier
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23737967/pdf/?tool=EBI

Similar Items

In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope
by: Guillaume Larid, et al.
Published: (2021-06-01)

How RA Associated HLA-DR Molecules Contribute to the Development of Antibodies to Citrullinated Proteins: The Hapten Carrier Model
by: Jean Roudier, et al.
Published: (2022-06-01)

Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
by: Snir, O, et al.
Published: (2009)

CITRULLINATED alpha-ENOLASE: A MAJOR AUTOANTIGEN LINKING SMOKING AND HLA-DRB1 SHARED EPITOPE TO RHEUMATOID ARTHRITIS
by: Lundberg, K, et al.
Published: (2009)

Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients
by: H.M. Farouk, et al.
Published: (2009-09-01)

Evaluation of X Chromosome Inactivation with Respect to HLA Genetic Susceptibility in Rheumatoid Arthritis and Systemic Sclerosis.
by: Sami B Kanaan, et al.
Published: (2016-01-01)

Effect of Anti-Cyclic Citrullinated Peptide and HLA-DRB1 Subtypes on Clinical Disease Activity Index in Rheumatoid Arthritis Patients
by: Akbar Soleimani, et al.
Published: (2017-03-01)

Lipoxygenase-derived oxylipins are enriched in anti-citrullinated protein antibody (ACPA)-positive individuals at risk for developing rheumatoid arthritis
by: Liam J. O’Neil, et al.
Published: (2024-02-01)

Antibodies to Citrullinated Proteins (ACPA) Associate with Markers of Osteoclast Activation and Bone Destruction in the Bone Marrow of Patients with Rheumatoid Arthritis
by: Weronika Kurowska, et al.
Published: (2021-04-01)

PAD4 Immunization Triggers Anti-Citrullinated Peptide Antibodies in Normal Mice: Analysis With Peptide Arrays
by: Marie F. Hemon, et al.
Published: (2022-03-01)

HLA-DRB1 alleles in patients with rheumatoid arthritis
by: L A Taukumova, et al.
Published: (2004-08-01)

Hematological parameters in patients with rheumatoid arthritis and gene variants HLA-DRB1*04 and HLA-DRB1*03
by: Biljana Klimenta, et al.
Published: (2020-06-01)

Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients
by: Minjie Xu, et al.
Published: (2023-01-01)

Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research
by: Celia Cartagena García, et al.
Published: (2022-07-01)

Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort
by: Gaël Mouterde, et al.
Published: (2019-06-01)

Machine learning-based prediction of rheumatoid arthritis with development of ACPA autoantibodies in the presence of non-HLA genes polymorphisms.
by: Grzegorz Dudek, et al.
Published: (2024-01-01)

High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis
by: David Gomez-Cabrero, et al.
Published: (2016-11-01)

<i>HLA-DRB1*07:01</i> and *<i>08:02</i> Alleles Confer a Protective Effect Against ACPA-Positive Rheumatoid Arthritis in a Latin American Admixed Population
by: Patricia Castro-Santos, et al.
Published: (2020-12-01)

Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis.
by: Hall, F, et al.
Published: (1996)

The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical
by: Debbie M. Boeters, et al.
Published: (2017-05-01)

Shared epitope alleles remain a risk factor for anti-citrullinated proteins antibody (ACPA)--positive rheumatoid arthritis in three Asian ethnic groups.
by: Too Chun-Lai, et al.
Published: (2011-01-01)

CLINICAL IMPORTANCE OF DETERMINATION OF HLA-DRB1 LOCUS GENES IN RHEUMATOID ARTHRITIS
by: V. Guseva, et al.
Published: (2019-05-01)

Serum Levels of IL-22 and ACPA in Patients with Rheumatoid Arthritis
by: Zainab A. Aldhaher, et al.
Published: (2018-06-01)

Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity
by: Kevin Y. Cunningham, et al.
Published: (2023-04-01)

Association of human leukocyte antigen-DRB1 with anti-cyclic citrullinated peptide autoantibodies in Saudi patients with rheumatoid arthritis
by: Abdullah Alrogy, et al.
Published: (2017-01-01)

A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies
by: P. Louzada-Júnior, et al.
Published: (2008-06-01)

Frequency of HLA-DRB1 alleles in rheumatoid arthritis patients in Zahedan, southeast Iran
by: Sandoughi Mahnaz, et al.
Published: (2011-01-01)

ACPA Status Correlates with Differential Immune Profile in Patients with Rheumatoid Arthritis
by: Achilleas Floudas, et al.
Published: (2021-03-01)

ACPA-negative rheumatoid arthritis: From immune mechanisms to clinical translation
by: Ketian Li, et al.
Published: (2022-09-01)

RE: Association of human leukocyte antigen-DRB1 with anti-cyclic citrullinated peptide autoantibodies in Saudi patients with rheumatoid arthritis
by: Marwan Hmoud Adwan
Published: (2017-07-01)

Adalimumab-Induced Rhupus Syndrome in a Female Patient Affected with Anti-Citrullinated Protein Antibody (ACPA)-Positive Rheumatoid Arthritis (RA): A Case Report and Review of Literature
by: Ciro Manzo, et al.
Published: (2021-07-01)

No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
by: Handel, A, et al.
Published: (2010)

HLA-DRB1 influence on anti-TNF treatment in British Caucasian rheumatoid arthritis patients
by: Harrison, P, et al.
Published: (2006)

Protective effect of the HLA-DRB1*13:02 allele in Japanese rheumatoid arthritis patients.
by: Shomi Oka, et al.
Published: (2014-01-01)

A distinctive peptide binding motif for HLA-DRB1*0407, an HLA-DR4 subtype not associated with rheumatoid arthritis.
by: Davenport, M, et al.
Published: (1997)

Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso
by: Alfred Rakissida Ouedraogo, et al.
Published: (2023-10-01)

Long-term follow-up of patients with anti-cyclic citrullinated peptide antibody-positive connective tissue disease: a retrospective observational study including information on the HLA-DRB1 allele and citrullination dependency
by: Takeshi Iwasaki, et al.
Published: (2020-10-01)

Soluble HLA-G Expression Inversely Correlates With Fetal Microchimerism Levels in Peripheral Blood From Women With Scleroderma
by: Julie Di Cristofaro, et al.
Published: (2018-08-01)

MHC class III genes in rheumatoid arthritis and the differential association of HLA-DRB1 alleles with disease
by: Harney, S, et al.
Published: (2005)

HLA-DRB1*08:02 Is Associated with Bucillamine-Induced Proteinuria in Japanese Rheumatoid Arthritis Patients
by: Hiroshi Furukawa, et al.
Published: (2014-05-01)